Coronary heart disease 1

Common Name(s)

Coronary heart disease 1

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Coronary heart disease 1" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Coronary heart disease 1" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Coronary heart disease 1" returned 39 free, full-text research articles on human participants. First 3 results:

Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants.
 

Author(s): , Yuan Lu, Kaveh Hajifathalian, Majid Ezzati, Mark Woodward, Eric B Rimm, Goodarz Danaei

Journal: Lancet. 2014 Mar;383(9921):970-83.

 

Body-mass index (BMI) and diabetes have increased worldwide, whereas global average blood pressure and cholesterol have decreased or remained unchanged in the past three decades. We quantified how much of the effects of BMI on coronary heart disease and stroke are mediated through ...

Last Updated: 17 Mar 2014

Go To URL
Associations between interleukin-1 gene polymorphisms and coronary heart disease risk: a meta-analysis.
 

Author(s): Liang Zhou, Jianguang Cai, Gang Liu, Yuan Wei, Hui Tang

Journal: PLoS ONE. 2012 ;7(9):e45641.

 

A great number of studies regarding the associations between IL-1B-511, IL-1B+3954 and IL-1RN VNTR polymorphisms within the IL-1gene cluster and coronary heart disease (CHD) have been published. However, results have been inconsistent. In this study, a meta-analysis was performed ...

Last Updated: 2 Oct 2012

Go To URL
The role of mediastinal adipose tissue 11β-hydroxysteroid d ehydrogenase type 1 and glucocorticoid expression in the development of coronary atherosclerosis in obese patients with ischemic heart disease.
 

Author(s): Fatmahan Atalar, Selcuk Gormez, Baris Caynak, Gokce Akan, Gamze Tanriverdi, Sema Bilgic-Gazioglu, Demet Gunay, Cihan Duran, Belhhan Akpinar, Ugur Ozbek, Ahmet Sevim Buyukdevrim, Zeliha Yazici

Journal:

 

Visceral fat deposition and its associated atherogenic complications are mediated by glucocorticoids. Cardiac visceral fat comprises mediastinal adipose tissue (MAT) and epicardial adipose tissue (EAT), and MAT is a potential biomarker of risk for obese patients.

Last Updated: 10 Dec 2012

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Coronary heart disease 1" returned 2 free, full-text review articles on human participants. First 3 results:

The timing hypothesis and hormone replacement therapy: a paradigm shift in the primary prevention of coronary heart disease in women. Part 1: comparison of therapeutic efficacy.
 

Author(s): Howard N Hodis, Wendy J Mack

Journal: J Am Geriatr Soc. 2013 Jun;61(6):1005-10.

 

The long-held belief that outcome data from intervention trials in men are generalizable to women has created the framework in which the primary prevention of coronary heart disease (CHD) in women is viewed, but over the past decade, data have accumulated to refute such a supposition ...

Last Updated: 18 Jun 2013

Go To URL
34th Bethesda Conference: Task force #1--Identification of coronary heart disease risk: is there a detection gap?
 

Author(s): Richard C Pasternak, Jonathan Abrams, Philip Greenland, Lynn A Smaha, Peter W F Wilson, Nancy Houston-Miller

Journal: J. Am. Coll. Cardiol.. 2003 Jun;41(11):1863-74.

 

Last Updated: 11 Jun 2003

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

BIOFLOW-III Israel Satellite Registry
 

Status: Recruiting

Condition Summary: Coronary Artery Disease; Myocardial Ischemia; Diabetes Mellitus Type 1 or 2

 

Last Updated: 8 Apr 2014

Go to URL
BIOFLOW III Asia Registry
 

Status: Recruiting

Condition Summary: Coronary Artery Disease; Myocardial Ischemia; Diabetes Mellitus Type 1 or 2

 

Last Updated: 8 Apr 2014

Go to URL
GLP-1 Loading During Elective Percutaneous Coronary Intervention
 

Status: Not yet recruiting

Condition Summary: Angina Pectoris; Myocardial Infarction; Reperfusion Injury; Coronary Heart Disease

 

Last Updated: 29 Apr 2014

Go to URL